Daré Bioscience, Inc.
DARE
$1.92
$0.073.78%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 31.48% | 73.82% | 24.24% | -131.11% | 35.19% |
| Total Depreciation and Amortization | 215.83% | 8,250.00% | 4,868.04% | 2,887.66% | 1,525.93% |
| Total Amortization of Deferred Charges | -- | -520.55% | -- | -127.83% | -- |
| Total Other Non-Cash Items | 22.00% | -47.65% | -13.07% | -16.19% | -65.88% |
| Change in Net Operating Assets | -109.05% | -79.17% | 200.07% | -216.11% | -17.11% |
| Cash from Operations | -0.92% | -72.78% | 92.54% | -141.98% | 19.70% |
| Capital Expenditure | -- | 63.29% | -161.88% | 153.79% | -2,054.79% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 63.29% | -161.88% | 153.79% | -2,054.79% |
| Total Debt Issued | -- | -- | -13.35% | -- | -- |
| Total Debt Repaid | -476.44% | -182.59% | -365.14% | -680.39% | 6.59% |
| Issuance of Common Stock | -78.24% | 2,196.94% | -- | 159.56% | 102.79% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1,040.00% | -304.15% | -- | 412.50% | -257.14% |
| Cash from Financing | -390.15% | 300.71% | 4,173.65% | -137.95% | 1,661.43% |
| Foreign Exchange rate Adjustments | 239.69% | 61.18% | -69.87% | -11.64% | 133.42% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -15.34% | -63.36% | 448.11% | -141.53% | 21.58% |